The year in cardiovascular medicine 2020: heart failure and cardiomyopathies

H Bueno, B Moura, P Lancellotti… - European Heart …, 2021 - academic.oup.com
Heart failure (HF) prevalence remains high worldwide with significant sex-related and
regional differences in its presentation, management, and outcomes. In 2020, advances in …

[PDF][PDF] Prognostic markers in advanced heart failure

PP Godhiwala, S Acharya, S Kumar… - Journal of Evolution of …, 2021 - academia.edu
Heart Failure is a crippling condition with a very poor outcome. Advanced heart failure is the
endpoint in patients of heart failure. Mortality rates are significantly higher among these …

[HTML][HTML] Heart failure with mildly reduced and preserved ejection fraction: A review of disease burden and remaining unmet medical needs within a new treatment …

N Desai, E Olewinska, A Famulska, C Remuzat… - Heart Failure …, 2024 - Springer
This review provides a comprehensive overview of heart failure with mildly reduced and
preserved ejection fraction (HFmrEF/HFpEF), including its definition, diagnosis, and …

[HTML][HTML] The year in cardiovascular medicine 2021: heart failure and cardiomyopathies

J Bauersachs, RA de Boer, JA Lindenfeld… - Cardiologia …, 2022 - hrcak.srce.hr
Sažetak In the year 2021, the universal definition and classification of heart failure (HF) was
published that defines HF as a clinical syndrome with symptoms and/or signs caused by a …

[HTML][HTML] Association between platelet distribution width and prognosis in patients with heart failure

Y Sato, A Yoshihisa, K Watanabe, Y Hotsuki… - PLoS …, 2020 - journals.plos.org
Background The prognostic impact of platelet distribution width (PDW), which is a specific
marker of platelet activation, has been unclear in patients with heart failure (HF). Methods …

[HTML][HTML] Liver congestion assessed by hepatic vein waveforms in patients with heart failure

Y Sugawara, A Yoshihisa, S Ishibashi, M Matsuda… - CJC open, 2021 - Elsevier
Background It has been reported that the pattern of hepatic vein (HV) waveforms determined
by abdominal ultrasonography is useful for the diagnosis of hepatic fibrosis in patients with …

Impact of left ventricular chamber size on outcome in heart failure with preserved ejection fraction

S Ogawa, Y Nagatomo, M Takei, M Saji… - International Heart …, 2022 - jstage.jst.go.jp
Although heart failure with preserved ejection fraction (HFpEF) has a highly variable
phenotype, heterogeneity in left ventricular chamber size (LVCS) and its association with …

[HTML][HTML] B-type natriuretic peptide is associated with the occurrence of bleeding events in heart failure patients with a history of coronary artery disease

Y Sato, A Yoshihisa, R Takeishi, H Ohara… - Journal of …, 2022 - Elsevier
Background: Bleeding risk in heart failure (HF) patients with coronary artery disease (CAD)
has not yet been fully investigated. Methods: We analyzed the data of 677 patients with a …

[HTML][HTML] Soluble fibrin monomer complex is associated with cardio-and cerebrovascular events in patients with heart failure

A Yoshihisa, Y Sato, Y Kimishima, Y Ichijo… - IJC Heart & …, 2021 - Elsevier
Background A biomarker of fibrin formation, the soluble fibrin monomer complex (SFMC), is
abnormally elevated in a variety of clinical situations of hypercoagulability. The aim of the …

Prognostic effects of changes in right ventricular fractional area change in patients with heart failure

Y Sugawara, A Yoshihisa, R Takeishi, H Ohara… - Circulation …, 2022 - jstage.jst.go.jp
Background: It is still unclear whether changes in right ventricular function are associated
with prognosis in heart failure (HF) patients. This study aimed to examine the prognostic …